Correction to: Anti-mesothelin CAR-T immunotherapy in patients with ovarian cancer

被引：0
|
作者：
Jiannan Chen
Jianhua Hu
Lili Gu
Feng Ji
Fan Zhang
Miaomiao Zhang
Jun Li
Zhengliang Chen
Longwei Jiang
Yan Zhang
Ruifang Shi
Lihua Ma
Shaochang Jia
Ying Zhang
Qi Zhang
Junqing Liang
Shunyu Yao
Zhigang Hu
Zhigang Guo
机构：
[1] Nanjing Normal University,Jiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences
[2] Jinling Hospital of Nanjing University School of Medicine,Department of Biotherapy
[3] Nanjing Blue Shield Biotechnology Co.,Department of Pathology
[4] Ltd.,Center of Interventional Radiology and Vascular Surgery, Department of Radiology, Zhongda Hospital, Medical School
[5] Jinling Hospital of Nanjing University School of Medicine,undefined
[6] Southeast University,undefined
[7] Inner Mongolia Autonomous Region Cancer Hospital,undefined
[8] Baylor University,undefined
来源：
Cancer Immunology, Immunotherapy | 2023年 / 72卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3401 / 3403
页数：2
相关论文
共 50 条
  • [1] Anti-mesothelin CAR-T immunotherapy in patients with ovarian cancer
    Jiannan Chen
    Jianhua Hu
    Lili Gu
    Feng Ji
    Fan Zhang
    Miaomiao Zhang
    Jun Li
    Zhengliang Chen
    Longwei Jiang
    Yan Zhang
    Ruifang Shi
    Lihua Ma
    Shaochang Jia
    Ying Zhang
    Qi Zhang
    Junqing Liang
    Shunyu Yao
    Zhigang Hu
    Zhigang Guo
    [J]. Cancer Immunology, Immunotherapy, 2023, 72 : 409 - 425
  • [2] Anti-mesothelin CAR-T immunotherapy in patients with ovarian cancer
    Chen, Jiannan
    Hu, Jianhua
    Gu, Lili
    Ji, Feng
    Zhang, Fan
    Zhang, Miaomiao
    Li, Jun
    Chen, Zhengliang
    Jiang, Longwei
    Zhang, Yan
    Shi, Ruifang
    Ma, Lihua
    Jia, Shaochang
    Zhang, Ying
    Zhang, Qi
    Liang, Junqing
    Yao, Shunyu
    Hu, Zhigang
    Guo, Zhigang
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023, 72 (02) : 409 - 425
  • [3] Anti-mesothelin CAR-T immunotherapy in patients with ovarian cancer (vol 72, pg 409, 2023)
    Chen, Jiannan
    Hu, Jianhua
    Gu, Lili
    Ji, Feng
    Zhang, Fan
    Zhang, Miaomiao
    Li, Jun
    Chen, Zhengliang
    Jiang, Longwei
    Zhang, Yan
    Shi, Ruifang
    Ma, Lihua
    Jia, Shaochang
    Zhang, Ying
    Zhang, Qi
    Liang, Junqing
    Yao, Shunyu
    Hu, Zhigang
    Guo, Zhigang
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023, 72 (10) : 3401 - 3403
  • [4] Repurposing anti-mesothelin CAR-NK immunotherapy against colorectal cancer
    Torchiaro, Erica
    Cortese, Marco
    D'Andrea, Alice
    Petti, Consalvo
    Medico, Enzo
    [J]. CANCER RESEARCH, 2024, 84 (07)
  • [5] Efficient growth suppression in pancreatic cancer PDX model by fully human anti-mesothelin CAR-T cells
    Hua Jiang
    Bo Song
    Peng Wang
    Bizhi Shi
    Qixiang Li
    Mingliang Fan
    Shengmeng Di
    Jie Yang
    Zonghai Li
    [J]. Protein & Cell, 2017, 8 (12) : 926 - 939
  • [6] Efficient growth suppression in pancreatic cancer PDX model by fully human anti-mesothelin CAR-T cells
    Jiang, Hua
    Song, Bo
    Wang, Peng
    Shi, Bizhi
    Li, Qixiang
    Fan, Mingliang
    Di, Shengmeng
    Yang, Jie
    Li, Zonghai
    [J]. PROTEIN & CELL, 2017, 8 (12) : 926 - 931
  • [7] Anti-mesothelin antibodies and circulating mesothelin relate to the clinical state in ovarian cancer patients
    Hellstrom, Ingegerd
    Friedman, Eitan
    Verch, Thorsten
    Yang, Yi
    Korach, Jacob
    Jaffar, Jade
    Swisher, Elizabeth
    Zhang, Boxin
    Ben-Baruch, Gilad
    Tan, Marcus C. B.
    Goedegebuure, Peter
    Hellstrom, Karl Erik
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2008, 17 (06) : 1520 - 1526
  • [8] ImmunoPET with Anti-Mesothelin Antibody in Patients with Pancreatic and Ovarian Cancer before Anti-Mesothelin Antibody-Drug Conjugate Treatment
    Lamberts, Laetitia E.
    van Oordt, Catharina W. Menke-van der Houven
    ter Weele, Eva J.
    Bensch, Frederike
    Smeenk, Michiel M.
    Voortman, Johannes
    Hoekstra, Otto S.
    Williams, Simon P.
    Fine, Bernard M.
    Maslyar, Daniel
    de Jong, Johan R.
    Gietema, Jourik A.
    Schroder, Carolien P.
    Bongaerts, Alphons H. H.
    Lub-de Hooge, Marjolijn N.
    Verheul, Henk M. W.
    Bohorquez, Sandra M. Sanabria
    Glaudemans, Andor W. J. M.
    de Vries, Elisabeth G. E.
    [J]. CLINICAL CANCER RESEARCH, 2016, 22 (07) : 1642 - 1652
  • [9] Tumor resistance to anti-mesothelin CAR-T cells caused by binding to shed mesothelin is overcome by targeting a juxtamembrane epitope
    Liu, X. F.
    Onda, M.
    Schlomer, J.
    Bassel, L.
    Kozlov, S.
    Tai, C. -H.
    Zhou, Q.
    Liu, W.
    Tsao, H. -E.
    Hassan, R.
    Ho, M.
    Pastan, I.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2024, 121 (04)
  • [10] Anti-Mesothelin CAR T cell therapy for malignant mesothelioma
    Castelletti, Laura
    Yeo, Dannel
    van Zandwijk, Nico
    Rasko, John E. J.
    [J]. BIOMARKER RESEARCH, 2021, 9 (01)
12345